Company
Vimatx
Advancing a new era in treatment to help people gain control of movement
Also known as Vima Therapeutics
- Status
- Operatingas of 2026-09-17
- Headquarters
- Cambridge, MA, United States
Claim, correct or request removal
Record updated 17 September 2026
About
Vima Therapeutics is on a mission to change the lives of people living with dystonia and Parkinson's disease by developing a novel oral therapy designed to help patients regain control of their movement.
Funding snapshot
- Total raised
- $100MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $100M2026-03-11
Funding rounds
- Series A
- $100M2026-03-11, Company stated
Loading relationship preview